NHC:NYE-National HealthCare Corporation (USD)

COMMON STOCK | Medical Care Facilities |

Last Closing

USD 137.13

Change

0.00 (0.00)%

Market Cap

USD 2.12B

Volume

0.04M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-08-31 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap
HCA HCA Holdings Inc

+3.01 (+0.77%)

USD 101.08B
UHS Universal Health Services Inc

+1.20 (+0.52%)

USD 15.29B
THC Tenet Healthcare Corporation

+4.40 (+2.78%)

USD 14.70B
DVA DaVita HealthCare Partners Inc

+5.92 (+3.76%)

USD 12.58B
EHC Encompass Health Corp

+0.65 (+0.70%)

USD 9.40B
CHE Chemed Corp

+5.54 (+0.97%)

USD 8.57B
AMN AMN Healthcare Services Inc

+3.46 (+7.92%)

USD 1.66B
AGL agilon health Inc

+0.22 (+6.65%)

USD 1.36B
BKD Brookdale Senior Living Inc

+0.16 (+2.46%)

USD 1.31B
CYH Community Health Systems Inc

+0.12 (+2.14%)

USD 0.79B

ETFs Containing NHC

COAL Exchange Traded Concepts .. 5.00 % 0.00 %

+0.37 (+1.83%)

USD 4.10M
CGV Two Roads Shared Trust 2.18 % 0.00 %

+0.13 (+1.83%)

USD 0.10B
SDGPEX:SW iShares STOXX Global Sele.. 2.12 % 0.00 %

N/A

N/A
ISPA:XETRA iShares STOXX Global Sele.. 1.95 % 0.00 %

+0.24 (+1.83%)

USD 2.30B
D100:XETRA MULTI-UNITS LUXEMBOURG - .. 1.88 % 0.00 %

+0.60 (+1.83%)

USD 0.04B
AFSM First Trust Active Factor.. 1.31 % 0.00 %

+0.72 (+1.83%)

USD 0.01B
ROSC Hartford Multifactor Smal.. 0.97 % 0.00 %

+1.07 (+1.83%)

USD 0.03B
DESC 0.00 % 0.30 %

N/A

N/A
KOL 0.00 % 0.60 %

N/A

N/A
RNSC First Trust Small Cap US .. 0.00 % 0.60 %

+0.56 (+1.83%)

USD 0.03B
ISPA:F iShares (DE) I - iShares .. 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Medical Care Facilities) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 48.38% 73% C 91% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 48.38% 73% C 91% A-
Trailing 12 Months  
Capital Gain 103.94% 82% B 93% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 103.94% 82% B 93% A
Trailing 5 Years  
Capital Gain 69.72% 72% C 77% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 69.72% 72% C 77% C+
Average Annual (5 Year Horizon)  
Capital Gain 9.43% N/A N/A 67% D+
Dividend Return 12.65% N/A N/A 70% C-
Total Return 3.22% N/A N/A 62% D
Risk Return Profile  
Volatility (Standard Deviation) 33.09% N/A N/A 30% F
Risk Adjusted Return 38.23% N/A N/A 57% F
Market Capitalization 2.12B 68% D+ 67% D+

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Underpriced compared to book value

The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Poor return on assets

The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.

Poor capital utilization

The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.

Poor return on equity

The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.